{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:14:09Z","timestamp":1762521249588},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/rlu.0b013e31818866bf","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T07:08:44Z","timestamp":1224054524000},"page":"752-756","source":"Crossref","is-referenced-by-count":54,"title":["Clinical Impact of Somatostatin Receptor Scintigraphy in the Management of Tumor-induced Osteomalacia"],"prefix":"10.1097","volume":"33","author":[{"given":"Mich\u00e8le","family":"Duet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Kerkeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Sfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Bazille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Liot\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Orcel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","article-title":"Phosphaturic mesenchymal tumors: a polymorphus group causing osteomalacia or rickets.","volume":"59","author":"Weidner","year":"1987","journal-title":"Cancer"},{"key":"R2-4-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity.","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R3-4-20210204","first-page":"1922","article-title":"Somatostatin and vaso-active intestinal peptide receptors in human mesenchymal tumors: in vitro identification.","volume":"56","author":"Reubi","year":"1996","journal-title":"Cancer Res"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia.","volume":"345","author":"Seufert","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-4-20210204","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1480269","article-title":"Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia.","volume":"148","author":"Larsson","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"28265","DOI":"10.1074\/jbc.M202527200","article-title":"Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway.","volume":"277","author":"Yamashita","year":"2002","journal-title":"J Biol Chem"},{"key":"R7-4-20210204","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","article-title":"Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor and F-18 fluorodeoxyglucose PET\/CT scan for the diagnosis and follow-up in one case.","volume":"36","author":"Dupont","year":"2005","journal-title":"Bone"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajmg.a.30599","article-title":"Elevated fibroblast factor-23 in hypophosphatemic linear nevus sebaceous syndrome.","volume":"134","author":"Hoffman","year":"2005","journal-title":"Am J Med genet A"},{"key":"R10-4-20210204","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.2001.01056.x","article-title":"Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.","volume":"54","author":"Rhee","year":"2001","journal-title":"Clin Endocrinol"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJM200205303462215","article-title":"Octreotide for tumor-induced osteomalacia.","volume":"346","author":"Paglia","year":"2002","journal-title":"N Engl J Med"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia.","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA"},{"key":"R13-4-20210204","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bone.2006.07.027","article-title":"A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: descrition of the biochemical response of FGF23 to octreotide therapy and surgery.","volume":"40","author":"Elson","year":"2007","journal-title":"Bone"},{"key":"R14-4-20210204","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2265.1997.3361119.x","article-title":"Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide.","volume":"47","author":"Broson-Chazot","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R15-4-20210204","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc070347","article-title":"Radiofrequency ablation of a tumor causing oncogenic osteomalacia.","volume":"357","author":"Hesse","year":"2007","journal-title":"N Engl J Med"},{"key":"R16-4-20210204","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","article-title":"Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia.","volume":"24","author":"Nguyen","year":"1999","journal-title":"Clin Nucl Med"},{"key":"R17-4-20210204","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging.","volume":"359","author":"Jan de Beur","year":"2002","journal-title":"The Lancet"},{"key":"R18-4-20210204","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00264-001-0318-0","article-title":"Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia.","volume":"26","author":"Moran","year":"2002","journal-title":"Int Orthop"},{"key":"R19-4-20210204","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00003072-200208000-00007","article-title":"Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report.","volume":"27","author":"Garcia","year":"2002","journal-title":"Clin Nucl Med"},{"key":"R20-4-20210204","first-page":"493","article-title":"A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan.","volume":"21","author":"Casari","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1200\/JCO.2005.05.043","article-title":"Case 3. Oncogenic osteomalacia associated with hemangiopericytoma localized by octreotide scan.","volume":"23","author":"Auethavekiat","year":"2005","journal-title":"J Clin Oncol"},{"key":"R22-4-20210204","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","article-title":"Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor and F-18 fluorodeoxyglucose PET\/CT scan for the diagnosis and follow-up in one case.","volume":"36","author":"Dupont","year":"2005","journal-title":"Bone"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-2005-837403","article-title":"Oncogenic osteomalacia in a 49-year-old female patient.","volume":"130","author":"Ludwig","year":"2005","journal-title":"Dtsch Med Wochenschr"},{"key":"R24-4-20210204","first-page":"9","article-title":"Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.","volume":"27","author":"Tartaglia","year":"2006","journal-title":"G Chir"},{"key":"R25-4-20210204","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-021919","article-title":"Clinical case seminar: fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia.","volume":"88","author":"Nelson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-4-20210204","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bone.2006.07.027","article-title":"A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery.","volume":"40","author":"Elston","year":"2007","journal-title":"Bone"},{"key":"R28-4-20210204","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/01.rlu.0000238192.37389.28","article-title":"Coexisting hyperparathyroidism and oncogenic osteomalacia: sestamibi and somatostatin receptor scintigraphy.","volume":"31","author":"Nguyen","year":"2006","journal-title":"Clin Nucl Med"},{"key":"R29-4-20210204","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1359\/jbmr.060909","article-title":"Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.","volume":"22","author":"Hesse","year":"2007","journal-title":"J Bone Miner Res"},{"key":"R30-4-20210204","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.rlu.0000257180.03964.51","article-title":"PET\/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia.","volume":"32","author":"Roarke","year":"2007","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003072-200811000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:12:16Z","timestamp":1618038736000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-200811000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e31818866bf","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}